Vets Invited to Test ECG Monitoring Device by HACARUS and DS Pharma Animal Health

Vets Invited To Test ECG Monitoring Device By HACARUS And DS Pharma Animal Health

Vets nationwide can now try-out the AI device to collect and visualize vital heart data straight from the dog’s paw.

Osaka, Japan, June 10, 2021 – Hacarus Inc, the provider of big insights from small data, today announced that DS Pharma Animal Health Co., Ltd. will begin nationwide rollout for vets who are willing to test the ECG monitoring device, co-developed between the two firms. The device is able to collect vital heart data using an innovative electrode device. Test results are then processed using HACARUS’ AI to provide timely and accurate insights.

“We are thrilled to be taking part in a project that has the potential to improve the care provided by veterinarians, and improve the lives of pet owners, and our canine friends. It is wonderful to see that we are now able to offer even more animal clinics the opportunity to experience the benefits of AI powered monitoring devices.” said Kenshin Fujiwara, CEO at HACARUS.

Vets can apply to be a tester from June 9th. Trials are available at partnered clinics in Japan, with the goal of testing at least 40 dogs per clinic using a convenient 5-minute test. Testing is only available for dogs at this time. This AI-powered ECG monitoring device will provide veterinarians with a simple and effective solution while eliminating the need for complex procedures that stress or agitate the four-legged patients.

The development of the non-invasive ECG data analysis tool began in 2018 after HACARUS won the ‘New Business Solutions in Animal Health’ program, held by DS Pharma Animal Health. The tool has a unique design that collects data directly from the dog’s paw as it stands on top of the device. These readings are then analyzed by HACARUS’ proprietary AI system to provide fast and accurate insights.

Moving forward, HACARUS will continue its efforts to improve health practices for animals and those who look after them with Lightweight and Explainable AI.


About DS Pharma Animal Health Co., Ltd.

DS Pharma Animal Health Co., LTD, established in July of 2010, is Japan’s largest provider of animal services. It aims to improve the lives of its customers by utilizing science to support animal health. To support animal lovers, DS Pharma is involved with the manufacturing, sales, and development of medical equipment and medicine for animals. To learn more, visit



HACARUS INC. provides big insights from small data, and has since its founding in 2014 supplied solutions in 100+ AI projects across the Medical and Manufacturing fields. Headquartered in Kyoto, Japan and backed by Osaka Gas and Miyako Capital (Kyoto University) among others, its technology enables humans to make better, faster and more reliable decisions, based on data driven insights. HACARUS’ proprietary AI engine is built using Sparse Modeling, a method that understands data like a human would – by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning. To learn more, visit

Takashi Someda

CTO of Hacarus. Has over 15 years experience as a software and server engineer in several global SaaS startups. Currently working hard to make something new with machine learning. Holds masters degree in Information Science at Kyoto University.

Subscribe to our newsletter

Click here to sign up